RESUMO
The authors describe recent developments in three areas of pediatrics commonly encountered by the office practitioner. First, clinical assessment of jaundice remains critically important as "early discharge" of newborns continues. Practitioners constantly balance clinical realities with an evidence-based approach in the management and follow-up of neonatal hyperbilirubinemia. Second, given the frequent exposure of children to animals, a thorough understanding of animal bites, pet-borne infections, and rabies prophylaxis is essential for every pediatrician. Finally, immunization status remains one of our leading health indicators. Recent changes in the routine immunization schedule and a renewed emphasis on vaccine safety provide insight into the future direction of vaccinology.
Assuntos
Doenças Transmissíveis/transmissão , Reservatórios de Doenças , Imunização , Icterícia Neonatal , Animais , Animais Domésticos , Mordeduras e Picadas/terapia , Gatos , Pré-Escolar , Doenças Transmissíveis/microbiologia , Doenças Transmissíveis/virologia , Cães , Humanos , Lactente , Recém-Nascido , Icterícia Neonatal/diagnóstico , Icterícia Neonatal/terapiaRESUMO
BACKGROUND AND OBJECTIVES: Identification of the epidural space is often performed using the loss-of-resistance technique (LOR), commonly with air or saline. The effect of air or saline on the quality of labor epidural analgesia has not been adequately studied. METHODS: Women who requested labor epidural analgesia were randomly assigned to 1 of 2 groups depending on the syringe contents used for the LOR technique and injected into the epidural space. In the air group (n = 80) the anesthesiologist used 2 mL of air, and in the saline group (n = 80) the anesthesiologist used 2 mL of 0.9% saline. After LOR was obtained, a multiorifice epidural catheter was threaded 5 cm into the epidural space and 13 mL of bupivacaine 0.25% was administered in divided doses. The success of the epidural block was determined by asking the patient if she required additional medication 15 minutes later. The occurrence of paresthesias and intravascular or subarachnoid catheters was noted. RESULTS: In the air group, 36% of patients requested additional pain medication, and in the saline group 19% requested additional medication (P =.022). We were not able to find a statistically significant difference between groups in the incidence of paresthesias (42% air v 51% saline), intravascular catheters (5% air v 8% saline), or subarachnoid catheters (0 in both groups). CONCLUSIONS: Using 0.9% saline for the LOR technique is associated with better analgesia as compared with air for labor analgesia, and this advantage should be considered when selecting the syringe contents for the LOR technique.
Assuntos
Analgesia Epidural , Analgesia Obstétrica , Espaço Epidural , Cloreto de Sódio/administração & dosagem , Adolescente , Adulto , Feminino , Humanos , Gravidez , Estudos ProspectivosRESUMO
The authors describe current investigation and most recent developments in three areas of pediatrics commonly faced by the office practitioner. The impetus of earlier newborn discharge places increased emphasis on pediatricians to accurately predict clinically significant jaundice. A better understanding of the pathophysiology of breastfeeding and breast milk jaundice, and the realization that Gilbert's syndrome may play a greater role in neonatal jaundice, only help confirm that the story of neonatal jaundice is still unfolding. Animal (particularly canine) bite injuries continue to be the most common animal-induced injuries, and a thorough review of appropriate antibiotic treatment and rabies prophylaxis guidelines are essential for the pediatric practitioner. During the past year, several major changes involving the use of rotavirus, pneumococcal, polio, meningococcal, and hepatitis A vaccines have taken place, which will have marked impact not only on pediatric office practice, but also on society as a whole.
Assuntos
Mordeduras e Picadas , Icterícia Neonatal/terapia , Vacinação , Animais , Mordeduras e Picadas/microbiologia , Mordeduras e Picadas/terapia , Aleitamento Materno , Gatos , Criança , Cães , Doença de Gilbert/diagnóstico , Vacinas contra Hepatite A/administração & dosagem , Humanos , Lactente , Recém-Nascido , Icterícia Neonatal/diagnóstico , Vacinas Meningocócicas/administração & dosagem , Vacinas Pneumocócicas/administração & dosagem , Vacinas contra Poliovirus/administração & dosagem , Vacinas contra Rotavirus/efeitos adversos , Infecções por Salmonella/prevenção & controleRESUMO
OBJECTIVES: To evaluate an encounter-based immunization prompting system on resident performance in administering vaccines and knowledge of immunization guidelines. DESIGN/METHODS: Prospective randomized, controlled trial. Subjects were first- and second-year pediatric residents in a hospital-based continuity clinic. The intervention group received manual prompts of immunizations due. Postclinic chart review compared immunizations due with those administered. Acceptable and unacceptable reasons for not administering vaccines were assigned. Resident knowledge was measured by a 70-item examination. RESULTS: The intervention group had significantly less missed opportunities/vaccine administration errors (11.4% vs 21.6%). The most common reason for unacceptable errors in the intervention group: vaccine was given too early; in the control group: vaccine was postponed to next visit. Pre- and postintervention knowledge scores were similar: intervention group (75.5% vs 80.7%, control group; 76.5% vs 81.3%). CONCLUSION: An immunization prompting system in a hospital-based pediatric resident continuity clinic reduced missed opportunities/vaccine administration errors without significantly impacting resident knowledge of immunization guidelines.immunization schedule, vaccination, immunization, prompting systems, resident education.
Assuntos
Esquemas de Imunização , Internato e Residência , Pediatria/educação , Sistemas de Alerta , Vacinação/estatística & dados numéricos , Adulto , Pré-Escolar , Humanos , Lactente , Estudos ProspectivosRESUMO
OBJECTIVES: Several pediatric advisory groups have recommended selective screening for dyslipidemia in children. Low-density lipoprotein cholesterol (LDL-C) is measured clinically with the Friedewald calculation in fasting samples. Nonfasting measurement of LDL-C would be clinically useful in children. DESIGN AND METHODS: In the present study, we examine the performance of two surfactant-based direct LDL-C assays in paired samples, fasting and nonfasting, from 100 children. RESULTS: LDL-C in the fasting state was significantly lower with the Friedewald estimation: 2.43 +/- 0. 61 mmol/L, N-geneous (Genzyme Corp.) direct LDL-C: 2.30 +/- 0.59 mmol/L, and Roche (Roche Diagnostics) direct LDL-C: 2.32 +/- 0.57 mmol/L than with ultracentrifugation-dextran-sulfate-Mg(2+) precipitation (UC-DS): 2.47 +/- 0.64 mmol/L. Moreover, there was increased negative bias using nonfasting samples with N-geneous: 2. 25 +/- 0.56 mmol/L and Roche: 2.26 +/- 0.56 mmol/L compared with fasting UC-DS. Correlation with US-DS was highest for Friedewald (r = 0.974) and fasting N-geneous (r = 0.973), and lowest with nonfasting N-geneous (r = 0.849) and Roche in fasting (r = 0.891) and nonfasting samples (r = 0.747). The sensitivity at LDL-C concentration of 2.85 mmol/L for the two direct methods when either fasting or nonfasting samples were used, was lower than that obtained with Friedewald. CONCLUSION: Overall, these direct LDL-C assays demonstrated limited utility in screening children but may be useful in the management of lipid disorders.
Assuntos
LDL-Colesterol/sangue , Hiperlipidemias/diagnóstico , Autoanálise/métodos , Boston , Criança , Serviços de Saúde da Criança , Pré-Escolar , Colesterol/sangue , HDL-Colesterol/sangue , Ingestão de Alimentos , Jejum , Feminino , Humanos , Hiperlipidemias/sangue , Masculino , Kit de Reagentes para Diagnóstico , Valores de Referência , Análise de Regressão , Reprodutibilidade dos Testes , Tensoativos , Triglicerídeos/sangueRESUMO
The authors describe current investigation in three areas of pediatrics commonly faced by the office practitioner. Despite the fact that changes in medical practice and in patient demographics have resulted in the reemergence of severe hyperbilirubinemia and bilirubin encephalopathy, clinical assessment and evaluation of discharge bilirubin levels may help predict those infants at greatest risk. Progress in the use of inhibitors of bilirubin production may eventually decrease the need for phototherapy. Although dog-associated injuries continue to affect children disproportionately, additional attention to anticipatory guidance may prove beneficial. The practice of routine immunization has reshaped our view of pediatric illness. The development of pneumococcal, meningococcal, and rotaviral vaccines will alter significantly the prevalence of common pediatric infectious disease. However, with the advent of additional vaccines, attention to pain control will take on increasing urgency.
Assuntos
Mordeduras e Picadas/diagnóstico , Mordeduras e Picadas/terapia , Cães , Imunização/métodos , Icterícia Neonatal/diagnóstico , Icterícia Neonatal/terapia , Visita a Consultório Médico , Pediatria/métodos , Animais , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Icterícia Neonatal/sangue , Icterícia Neonatal/etiologiaAssuntos
Analgesia Epidural , Analgesia Obstétrica , Isoproterenol/farmacologia , Feminino , Humanos , Gravidez , Fatores de TempoRESUMO
OBJECTIVE: Previous work has focused attention on the prevalence of specific maternal health problems known to affect children, such as smoking or depression. However, the cumulative health burden experienced by mothers and the potential for a practical pediatric health services response have not been examined. The aims of this study were to characterize: 1) the prevalence and cumulative burden of maternal health behaviors and conditions, 2) maternal access to a source of comprehensive adult primary care, and 3) maternal perceptions of a pediatric role in screening and referral. METHODS: We surveyed 559 consecutive women bringing a child 18 months of age or less to one of four pediatric primary care sites between July 1996 and May 1997. The pediatric sites included one outpatient program in an academic hospital, one in a community health center, and two in-staff model practices of a managed care organization (these last two were combined for analysis). The self-administered questionnaire contained previously validated questions to assess health behaviors and conditions (smoking, alcohol abuse, depression, violence, risk for unintended pregnancy, serious illness, self-reported health) and access to care (regular source, regular provider, health insurance, care delayed or not received). Maternal attitudes toward a pediatric role in screening and referral were also elicited. RESULTS: In the three settings, response rates ranged from 75% to 84%. The average age of the women ranged from 25.1 to 32. 1 years and the average age of the children ranged from 6.5 to 8.0 months. Across the settings, the percentage of women reporting at least one health condition (66%-74%) was similarly high, despite significant demographic differences among sites. Many women reported more than one condition (31%-37%); among all women who smoked, 33% also screened positive for alcohol abuse, 31% for emotional or physical abuse, and 48% for depression. Access to comprehensive adult primary care was variable with 23% to 58% of women reporting one or more barriers depending on the site. Across all sites, >85% of mothers reported they would "not mind" or "would welcome" a pediatric role in screening and referral. CONCLUSIONS: Two-thirds of women bringing their children for pediatric care had health problems regardless of the site of care. Many women also reported substantial barriers to comprehensive health care. Most women reported acceptance of a pediatric role in screening and referral. Given the range and depth of maternal health needs, strategies to connect or reconnect mothers to comprehensive adult primary care from a variety of pediatric settings should be explored.
Assuntos
Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Serviços de Saúde Materna/estatística & dados numéricos , Bem-Estar Materno/estatística & dados numéricos , Adulto , Boston , Proteção da Criança/estatística & dados numéricos , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Lactente , Avaliação das Necessidades , Atenção Primária à SaúdeRESUMO
This review presents in a clinically relevant context the past year's investigations in three areas of pediatrics that commonly face the office-based pediatric provider. Although transcutaneous quantification of jaundice may help discern which patients warrant further evaluation, thereby saving patients pain and expense, this technology has not yet significantly changed clinical management of the hyperbilirubinemic infant. A brief overview of animal bites demonstrates that although most are innocuous, proper treatment of these potentially serious injuries is critical in preventing further complications. The number of immunizations given in the first 2 years of life has increased, and although new combination vaccines may eventually simplify the schedule, persistent vigilance is more important than ever to avoid delays in vaccine administration.
Assuntos
Mordeduras e Picadas/diagnóstico , Mordeduras e Picadas/terapia , Imunização , Icterícia Neonatal/diagnóstico , Icterícia Neonatal/terapia , Mordeduras e Picadas/complicações , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Visita a Consultório Médico , PediatriaRESUMO
BACKGROUND: Approximately 15% of women still have pain after placement of an epidural catheter and administration of local anesthetic for labor analgesia. Two techniques frequently used to treat this pain were compared: (1) withdrawal of the catheter 1 cm and repeated dosing with additional local anesthetic, and (2) repeated dosing with additional local anesthetic without any catheter manipulation. METHODS: Fifteen minutes after placement of a multiple-orifice epidural catheter 5 cm into the epidural space and administration of 13 ml 0.25% bupivacaine to the parturient in labor, the adequacy of analgesia was assessed. All women who had incomplete analgesia were randomized (first intervention) to receive an additional 5 ml 0.25% bupivacaine (local-anestheticonly group) or to receive 5 ml 0.25% bupivacaine after first withdrawing the epidural catheter 1 cm (catheter-manipulation group). If after 15 min the woman still had pain, then (second intervention) the catheter was withdrawn 1 cm and an additional 5 ml 0.25% bupivacaine was administered to the local-anesthetic-only group, whereas 5 ml 0.25% bupivacaine was given to the catheter-manipulation group without further catheter manipulation. The success rate of the second intervention was assessed 15 min later. RESULTS: Seventy-eight women were enrolled in the study, 39 to each group. In the local-anesthetic-only group, 29 (74%) women were successfully treated with the first intervention and the remaining 10 (100%) were successfully treated with the second intervention. In the catheter-manipulation group, 30 (77%) were successfully treated with the first intervention and 7 (100%; 2 patients were not studied because of investigator error) were successfully treated with the second intervention (P=NS). CONCLUSIONS: Administration of additional local anesthetic without first withdrawing the epidural catheter will effectively treat most women for whom analgesia is incomplete after the placement of an epidural catheter during labor.
Assuntos
Analgesia Epidural/métodos , Analgesia Obstétrica/métodos , Anestésicos Locais/administração & dosagem , Bupivacaína/administração & dosagem , Trabalho de Parto , Analgesia Epidural/instrumentação , Analgesia Obstétrica/instrumentação , Feminino , Humanos , GravidezRESUMO
UNLABELLED: The purpose of this study was to determine whether subhypnotic doses of propofol effectively relieve pruritus in women who received intrathecal morphine for postoperative analgesia after cesarean delivery. Twenty-nine women who developed pruritus after undergoing an elective cesarean section and receiving intrathecal morphine (0.25 mg) for postoperative analgesia were enrolled in this randomized, prospective, double-blind study. The women were randomly assigned to receive either 1 mL of propofol (n = 17) or 1 mL of placebo (n = 12) I.V. Pruritus was evaluated 5 min after treatment. In the absence of successful treatment, the women received another 1 mL of the same drug. Pruritus was again evaluated 5 min after the second dose. We found that pruritus was successfully treated twice in the propofol group and once in the placebo group (P = not significant). The antipruritic action of propofol lasted for up to 6 h in one woman and 15 min in the other. The one success in the placebo group lasted for 15 min. We conclude that the success rate of propofol in treating pruritus in women who received intrathecal morphine for postoperative analgesia after cesarean delivery is not significantly different from that of placebo. IMPLICATIONS: Pruritus is a common and bothersome side effect of neuraxial opioids after cesarean section. Subhypnotic doses of I.V. propofol (10 mg) have been used to treat pruritus caused by neuraxial opioids. In this prospective, randomized, double-blind study, we found that propofol does not relieve pruritus in women who underwent cesarean section and received intrathecal morphine sulfate (0.25 mg) for postoperative pain relief.
Assuntos
Morfina/efeitos adversos , Propofol/administração & dosagem , Prurido/prevenção & controle , Adulto , Cesárea , Método Duplo-Cego , Feminino , Humanos , Estudos ProspectivosRESUMO
UNLABELLED: The purpose of this study was to determine whether functionally active tissue factor could be removed from blood contaminated with amniotic fluid (AF) after processing through a Haemonetics 4 Cell Saver System (Haemonetics Corporation, Braintree, MA). In Phase I, AF was collected from 29 women undergoing cesarean section. Nine experiments were performed. Forty-milliliter aliquots of pooled AF were mixed with 125 mL of packed red blood cells and processed in the Cell Saver. In Phase II, all the blood and AF lost at cesarean section was collected and processed through the Cell Saver. Pre- and postwash specimens were collected and analyzed for total tissue factor concentration and the concentration of functionally active tissue factor. In Phase I, total tissue factor concentration was reduced by 89%, and the concentration of active tissue factor was reduced to 0 after processing. In Phase II, no tissue factor was detected after processing through the Cell Saver. We have demonstrated the ability of the Haemonetics 4 Cell Saver System to remove tissue factor activity from blood contaminated with AF. IMPLICATIONS: Hemorrhage after childbirth may require massive transfusion. If the patient's own blood can be collected and given back to the patient, this may avoid the use of regular banked blood. Amniotic fluid, which may mix with blood lost after delivery, contains tissue factor, a substance that may activate the coagulation system and cause further bleeding. The authors found that the Haemonetics 4 Cell Saver System (Haemonetics Corporation, Braintree, MA), which collects and washes blood, can remove tissue factor from blood contaminated with amniotic fluid.
Assuntos
Líquido Amniótico/química , Coleta de Amostras Sanguíneas , Tromboplastina/isolamento & purificação , Cesárea , Feminino , Humanos , GravidezRESUMO
To approximate the effect of prolonged storage on safety and immunogenicity, healthy children were given a single dose of the currently marketed live attenuated varicella vaccine (3625 pfu) or of a partially heat-inactivated vaccine (1125 or 439 pfu). The 3 doses had similar antigen content (attenuated plus inactive virus particles). The vaccine was well tolerated. No significant differences in adverse reactions were observed. Although the seroconversion rates were excellent at each dose (> or = 98%), the higher doses resulted in significantly greater geometric mean antibody titers at 6 weeks (10.5 and 10.6 ELISA U/mL) compared with the 439 pfu dose (5.7 ELISA U/mL), P < or = .01. One year after immunization, differences in antibodies were similar to the 6-week postimmunization results. Results indicate that until the date of expiry, the vaccine's immunogenicity will be preserved and there will be no clinically important changes in type or frequency of adverse events.
Assuntos
Vacina contra Varicela/imunologia , Vacinas de Produtos Inativados/imunologia , Anticorpos Antivirais/análise , Varicela/sangue , Varicela/imunologia , Vacina contra Varicela/administração & dosagem , Vacina contra Varicela/efeitos adversos , Criança , Pré-Escolar , Armazenamento de Medicamentos , Calefação/efeitos adversos , Humanos , Lactente , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/efeitos adversosRESUMO
This study was undertaken to assess women's knowledge and concerns about obstetric anesthesia and to determine if they perceive a need for an anesthesia interview before the onset of labor. A 17 item questionnaire was distributed to 407 women on postpartum day one. The women were questioned about their knowledge, anxiety and concerns regarding obstetric anesthesia. The questionnaire was completed by 320 women, 57% of whom were Caucasian and 28% of whom had some postgraduate education. Most of the women (74%) had either a regional or general anesthetic for their delivery and 86% of the women admitted to having some anxiety about anesthesia. Although 82% of the women attempted to obtain information about anesthesia before labor, 28% did not feel adequately informed. The majority (59%) of the women would have wanted a preoperative visit with an anesthesiologist before labor. These results illustrate that most women are anxious about obstetric anesthesia and do not feel adequately prepared. Efforts at educating women about obstetric anesthesia would be welcomed by them and methods to accomplish this goal are discussed.
RESUMO
OBJECTIVE: We compared the diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine (DTaP) responses in Japanese and United States infants. DESIGN: This was a double-blind, comparative study. SETTING: Private pediatric practices in Japan and the U.S. participated. SUBJECTS: One hundred eighty-nine healthy 2-month old infants were tested. INTERVENTIONS: Infants were immunized at 2, 4, and 6 months of age. The Japanese formulation (DTaP-J) contained 20 micrograms of pertussis toxin (PT) and 20 micrograms of filamentous hemagglutinin (FHA); the U.S. formulation (DTaP-US) contained 23.4 micrograms of each antigen. Parents used a standard form to record average adverse experiences. Serum was obtained before the first immunization, 2 months after the second immunization, and 1 month after the third immunization. MEASUREMENTS: Differences in DTaP-J and DTaP-US were evaluated in Japanese infants immunized subcutaneously (s.c.). Differences due to ethnicity and to route of administration were compared in U.S. infants immunized with DTaP-US s.c. or intramuscularly (i.m.). An indirect enzyme-linked immunosorbent assay was used to determine immunoglobulin G antibody responses to PT, FHA, and tetanus toxoid. Neutralizing antibody to PT was measured by a Chinese hamster ovary call assay. Diphtheria antitoxin was assayed by serum neutralization on VERO cells. RESULTS: Statistical differences (P < .05) in adverse events included less fatigue after immunization with DTaP-US compared with DTaP-J. Erythema of more than 2.5 cm was more frequent, but erythema less than 2.5 cm was less frequent in Japanese infants compared with U.S. infants. Fewer Japanese infants were febrile ( > 38 degrees C), tired, or irritable. Subcutaneous immunization resulted in a greater frequency of erythema and induration. The DTaP-US resulted in an equivalent response to PT and a greater response to FHA. More Japanese infants demonstrated at least a fourfold response over preimmunization antibody values to FHA. In U.S. infants, antibody responses to the contained pertussis antigens were equivalent after i.m. and s.c. administration. Compared with Japanese infants receiving DTaP-J s.c., U.S. infants receiving DTaP-US i.m. had equivalent responses to PT and a greater response to FHA. CONCLUSIONS: United States infants receiving an i.m. injection of a U.S. -produced bicomponent DTaP vaccine produced antibody responses to the contained pertussis antigens at least equal to those of Japanese infants receiving a similar bicomponent DTaP vaccine shown to be effective in older Japanese children.
Assuntos
Vacina contra Difteria, Tétano e Coqueluche/administração & dosagem , Método Duplo-Cego , Humanos , Lactente , Injeções Intramusculares , Injeções Subcutâneas , Japão , Estados UnidosRESUMO
Five hundred and fifty-seven infants received either an acellular pertussis (DTaP) vaccine containing pertussis toxoid (PT), filamentous hemagglutinin (FHA) and pertactin (PRN) or one of two commercially available whole-cell pertussis (DTP) vaccines at 2, 4 and 6 months. One month after the third immunization, IgG antibody values to pertussis toxoid, filamentous hemagglutinin and PRN were significantly greater following DTaP than either DTP (P < 0.05). When reactions within 48 h after all three doses of vaccine were combined, fever 101 degrees, > or = moderate fussiness, > or = moderate pain, swelling 10 mm, and erythema 10 mm occurred less often after DTaP compared with DTP-Connaught (P < 0.001). The same adverse events were also less after DTaP compared with DTP-Lederle (P < 0.05), except for erythema 10 mm. This three-component DTaP vaccine produced fewer adverse events and greater antibody values to PT, FHA and PRN in comparison with either licensed DTP vaccine when given as the primary series.
Assuntos
Bordetella pertussis/imunologia , Vacina contra Difteria, Tétano e Coqueluche/efeitos adversos , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Fatores de Virulência de Bordetella , Adesinas Bacterianas/imunologia , Anticorpos Antibacterianos/biossíntese , Proteínas da Membrana Bacteriana Externa/imunologia , Método Duplo-Cego , Feminino , Hemaglutininas/imunologia , Humanos , Esquemas de Imunização , Lactente , Masculino , Estudos Prospectivos , Toxoides/imunologiaRESUMO
Complications can occur during epidural placement for women in labor. As many as 23% of epidural anesthetics may not provide satisfactory analgesia. The cause of this may be technical. This study was undertaken to determine the optimal distance that a multiorifice catheter should be threaded into the epidural space to maximize analgesia and minimize complications. One hundred women in labor were enrolled in this prospective, randomized, and double-blind study. Patients were randomly assigned to have the epidural catheter threaded 3, 5, or 7 cm into the epidural space. After placement of the catheter and administration of a test dose with 3 mL of 0.25% bupivacaine, an additional 10 mL of 0.25% bupivacaine was administered in two divided doses. Fifteen minutes later, the adequacy of the analgesia was assessed by a blinded observer. We found that catheter insertion to a depth of 7 cm was associated with the highest rate of insertion complications while insertion to a depth of 5 cm was associated with the highest incidence of satisfactory analgesia. For women in labor who require continuous lumbar epidural anesthesia, we recommend threading a multiorifice epidural catheter 5 cm into the epidural space.
Assuntos
Analgesia Epidural/instrumentação , Analgesia Obstétrica/instrumentação , Analgesia Epidural/efeitos adversos , Analgesia Epidural/métodos , Analgesia Obstétrica/efeitos adversos , Analgesia Obstétrica/métodos , Bupivacaína/administração & dosagem , Cateterismo/instrumentação , Método Duplo-Cego , Espaço Epidural , Desenho de Equipamento , Falha de Equipamento , Feminino , Humanos , Bloqueio Nervoso , Medição da Dor , Parestesia/etiologia , Gravidez , Estudos Prospectivos , Espaço Subaracnóideo , Propriedades de Superfície , VeiasRESUMO
OBJECTIVE: To compare the safety and immunogenicity of a three-component acellular pertussis (DTaP) vaccine containing pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin with whole-cell pertussis (DTwP) vaccine in 4- through 6-year-old children. PARTICIPANTS: One hundred seventy-two healthy 4- through 6-year-old children previously immunized with the DTwP vaccine at or near 2, 4, 6, and 18 months of age. INTERVENTIONS: Prevaccination serum samples were obtained on all study participants. One hundred twelve children received 0.5 mL of the DTaP vaccine intramuscularly. Fifty-three children received 0.5 mL of a commercially available DTwP vaccine intramuscularly. Approximately 30 days following vaccination, additional serum samples were obtained. MEASUREMENTS: Parents monitored adverse reactions for 7 days following immunization. Significantly fewer children in the DTaP group reported temperatures of greater than 38.1 degrees C and an area of redness of more than 10 mm and moderate-to-severe pain at the injection site. RESULTS: Antibody responses to PT, FHA, pertactin, and diphtheria and tetanus toxoids were measured by enzyme-linked immunosorbent assay. Among subjects who were seronegative prior to vaccination, response was defined as the detection of antibody levels following vaccination; among children with detectable antibody levels prior to vaccination, in terms of the rise in antibody titers. Data using a twofold and a fourfold rise in antibody titers as criteria to define response were evaluated. Children in the DTaP group had significantly greater increases in geometric mean titers of antibodies against PT, FHA, and pertactin. Over 90% of the DTaP group responded to PT, FHA, and pertactin according to the criteria of both the twofold and the fourfold rise in antibody titers. Significantly fewer of the DTwP group responded to PT, FHA, and pertactin with at least a fourfold rise in antibody titers. When analyzing subjects with at least a twofold increase in antibody titers, a statistically significant difference remained in regard to anti-FHA antibodies. All study subjects had protective antibody titers against diphtheria and tetanus toxoids following vaccination. The geometric mean titer of antibodies against tetanus was significantly greater in the DTwP group than in the DTaP group. CONCLUSION: The three-component DTaP vaccine administered as a booster immunization in 4-through 6-year-old children produced less fever and less redness and pain at the injection site than the DTwP vaccine and was as immunogenic as the DTaP vaccine.